These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16260692)

  • 21. Surveillance in stage I testicular seminoma.
    Chung P; Warde P
    Urol Oncol; 2006; 24(1):75-9. PubMed ID: 16414499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.
    Steiner H; Höltl L; Wirtenberger W; Berger AP; Bartsch G; Hobisch A
    Urology; 2002 Aug; 60(2):324-8. PubMed ID: 12137835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late relapse of stage i seminoma following single-agent carboplatin.
    Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
    Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant carboplatin treatment for seminoma clinical stage I.
    Dieckmann KP; Krain J; Küster J; Brüggeboes B
    J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of treatment options for the management of stage I testicular seminoma.
    Bernal F; Raman JD
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1081-90. PubMed ID: 18588453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contralateral intratubular germ cell neoplasia in a patient with testicular cancer.
    Buchler T; Freeman A; Harland S
    Nat Clin Pract Urol; 2008 May; 5(5):284-8. PubMed ID: 18398407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
    J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage I seminoma and carboplatin risks.
    Horwich A
    Ann Oncol; 2008 Mar; 19(3):407-8. PubMed ID: 18227108
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial comment to outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Brassell SA
    Int J Urol; 2010 Dec; 17(12):988. PubMed ID: 21091794
    [No Abstract]   [Full Text] [Related]  

  • 31. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Kratzik C; Brodowicz T; Haitel A; Pokorny A; Zielinski CC; Marberger M
    Urology; 1998 Jul; 52(1):117-9. PubMed ID: 9671881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy in stage I and stage II testicular cancer.
    Albers P; Perabo FG; Melchior D; Siener R
    World J Urol; 2001 Apr; 19(2):76-81. PubMed ID: 11374321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
    Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
    Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spermatocytic seminoma. Apropos of 4 cases].
    Caty A; Bertrand P; Castelain B; Mazeman E
    Bull Cancer; 1997 Feb; 84(2):212-4. PubMed ID: 9180847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-dose carboplatin in seminoma.
    Oliver T
    Lancet; 2005 Oct 29-Nov 4; 366(9496):1526. PubMed ID: 16257338
    [No Abstract]   [Full Text] [Related]  

  • 37. Testicular seminoma: Are clinical features and treatment outcomes any different in India?
    Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
    Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
    Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
    J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumour markers--case report].
    Lamerz R; Stieber P
    Dtsch Med Wochenschr; 2004 Dec; 129(50):2721. PubMed ID: 15592973
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of stage A testicular seminoma by carboplatin monochemotherapy.
    Bojanić N; Mićić S; Vuksanović A; Vuković I; Janjić A
    Vojnosanit Pregl; 2009 Apr; 66(4):303-6. PubMed ID: 19432296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.